OpGen Corporation (OPGN) - Koefisien utang jangka dawa marang modal

OpGen, Inc. (OPGN) generates revenue from the sale of diagnostic systems, although its primary profit is driven by high-margin cloud software for drug resistance analysis. The digital environment they created helps medical professionals promptly select therapies against dangerous pathogens. The price trend reflected in this chart is 0.00, occurring against the backdrop of a deep debt crisis and attempts to sell off individual patents to ensure business survival.

This indicator compares liabilities with maturities exceeding one year against the amount of equity. The metric determines the extent to which the liability structure depends on external debt financing. For OpGen, Inc. (OPGN), this calculation is critical when scaling the network of diagnostic platforms in hospitals. The long-term debt-to-equity ratio allows for an assessment of financial stability during the deployment of costly infrastructure. The trend of this indicator on the chart reveals risks of excessive leverage.